US equities |
NVDA $238.92 ▲+2.12% SPCX $168.08 ▲+5.74% MU $1,059.89 ▼-1.40% TSLA $380.52 ▲+2.68% MSFT $527.26 ▲+1.88% SNDK $1,691.14 ▼-1.68% INTC $116.69 ▼-2.21% META $742.85 ▲+2.03%
FinancialContent

Akoya BioSciences, Inc. - Common Stock (NQ:AKYA)

1.290 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Akoya BioSciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic... 
Via Benzinga
News headline image
Why Shares of Akoya Biosciences Jumped on Tuesday ↗
A rash of insider buying buoyed investor confidence in the medical instrument company. 
Via The Motley Fool
News headline image
Akoya to Participate at Two Upcoming Investor Conferences
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Looking Into Akoya Biosciences's Return On Capital Employed ↗
 
Via Benzinga
News headline image
A Preview Of Akoya Biosciences's Earnings ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday, 35 stocks hit new 52-week lows. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Akoya Biosciences Announces Pricing of Public Offering of Common Stock
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Announces Public Offering of Common Stock
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Announces Leadership Transition
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
Simultaneous detection of proteins and RNA markers across 23 different tissue samples demonstrate robust and scalable capabilities of company’s multiomics solution 
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
From Agilent Technologies Inc.
Via Business Wire
News headline image
Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. 
Via Benzinga
News headline image
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast... 
Via Benzinga
News headline image
Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
From Akoya Biosciences, Inc.
Via GlobeNewswire
News headline image
Preview: Akoya Biosciences's Earnings ↗
Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Akoya... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >